- Home
- TARS vs HBI Comparison
TARS vs HBI Comparison
Compare TARS & HBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- HBI
- Stock Information
- Founded
- TARS 2016
- HBI 1901
- Country
- TARS United States
- HBI United States
- Employees
- TARS N/A
- HBI N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- HBI Clothing/Shoe/Accessory Stores
- Sector
- TARS Health Care
- HBI Consumer Discretionary
- Exchange
- TARS Nasdaq
- HBI Nasdaq
- Market Cap
- TARS 2.8B
- HBI 2.4B
- IPO Year
- TARS 2020
- HBI 2006
- Fundamental
- Price
- TARS $67.56
- HBI $6.93
- Analyst Decision
- TARS Strong Buy
- HBI Hold
- Analyst Count
- TARS 7
- HBI 5
- Target Price
- TARS $69.43
- HBI $6.60
- AVG Volume (30 Days)
- TARS 613.1K
- HBI 6.0M
- Earning Date
- TARS 11-04-2025
- HBI 11-06-2025
- Dividend Yield
- TARS N/A
- HBI N/A
- EPS Growth
- TARS N/A
- HBI N/A
- EPS
- TARS N/A
- HBI 0.25
- Revenue
- TARS $295,521,000.00
- HBI $3,540,309,000.00
- Revenue This Year
- TARS $139.46
- HBI $1.61
- Revenue Next Year
- TARS $49.91
- HBI N/A
- P/E Ratio
- TARS N/A
- HBI $27.51
- Revenue Growth
- TARS 254.45
- HBI 2.95
- 52 Week Low
- TARS $38.51
- HBI $3.96
- 52 Week High
- TARS $76.81
- HBI $9.10
- Technical
- Relative Strength Index (RSI)
- TARS 54.32
- HBI 62.93
- Support Level
- TARS $65.30
- HBI $6.71
- Resistance Level
- TARS $74.83
- HBI $6.97
- Average True Range (ATR)
- TARS 2.87
- HBI 0.14
- MACD
- TARS -0.99
- HBI -0.02
- Stochastic Oscillator
- TARS 19.64
- HBI 79.31
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About HBI Hanesbrands Inc.
Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated, as it produces nearly 75% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina. Hanesbrands has agreed to be acquired by Canadian rival Gildan.